Stephen Lemieux - 04 Aug 2023 Form 4 Insider Report for Edesa Biotech, Inc. (EDSA)

Reporting relationship: Chief Financial Officer
Issuer ticker: EDSA
Reported as of: 04 Aug 2023
Net transaction value: $0
SEC form: 4
Accepted by SEC: 04 Aug 2023, 16:19:03 UTC
Prior SEC filing: 24 Jul 2023
Source filing: View source filing
Reporting owner signature: /s/ Stephen Lemieux

Key filing fact

Stephen Lemieux filed Form 4 for Edesa Biotech, Inc. (EDSA) on 04 Aug 2023.

Key facts

This page summarizes Stephen Lemieux's Form 4 filing for Edesa Biotech, Inc. (EDSA).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 04 Aug 2023, 16:19.

Change

Previous filing in this sequence was filed on 24 Jul 2023.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

EDSA transaction

Common Shares

Award

Transaction value
Shares: +17,400
Change %
Price
Shares after: 17,400
Date: 04 Aug 2023
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Reflects a grant of restricted share units ("RSUs"), which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan. These RSUs represent awards received in lieu of certain compensation fees earned by Reporting Person. The number of RSUs was determined by dividing such fees by the 5-day volume weighted average price (VWAP) of the Issuer's common shares through July 31, 2023.